Skip to main content
Skip to main navigation
Search for :
Product Development Strategy
Early Clinical Development
Phase I/IIa Clinical Trials
Phase II/III Clinical Trials
Interventional Phase IIIb/Phase IV Clinical Trials
Observational Research & Registries
Product Launch & Management
Market Access Solutions
Strategic Sales Outsourcing
Biopharmaceutical Sales & Marketing
Healthcare Payers & Providers
Medical Device & Diagnostics
Public Health & Government
Central Nervous System
Diabetes & Endocrinology
Early Phase Oncology
Public Health Interest
Other Therapeutic Areas
Ethics & Compliance
Request a Proposal
Phone:+32 2 555 05 55
Phone:+1 514 855 0888
Phone:+31 23 567 0910
Quintiles Malaysia has been in operation since 2001, providing expert clinical services and innovative product marketing and sales solutions for our customers.
We offer experienced local staff, adherence to Quintiles global quality
standards and an understanding of the local environment, which allows us to delight our Biopharmaceutical clients. Quintiles Malaysia is based
at the heart of the country's capital, Kuala Lumpur.
Through our Malaysia-based team, we credibly and efficiently manage and support your Phase II and Phase III clinical trials.
Access these services in Malaysia or via our centers of excellence.
As regulatory boards are expecting more from clinical endpoint
committees, what guidance can you follow? This white paper sets forth
current best practice for CECs.
Read white paper
Turkey provides rapid patient enrollment with high patient retention
rates and remains an emerging market with few competing studies –
becoming a major hub for patient recruitment.
Read fact sheet
The work we do with the biopharmaceutical industry, payers and providers has a profound effect on extending patients’ lives and quality of life around the world.
Learn More About Quintiles